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236 Acceptability of continuous glucose monitoring (CGM) in cystic
ﬁbrosis
J. Gallagher1, J. Daniels1, D. Nazareth1, M. Ledson1, J. Greenwood1, M. Walshaw1.
1Liverpool Heart & Chest Hospital NHS Foundation Trust, Adult CF Unit,
Liverpool, United Kingdom
Objective: Real-time monitoring of glucose by CGM is a validated tool in the
management of diabetes, but its use in CF-related diabetes (CFRD) is new and the
attitudes of CF patients towards it are unknown. To assess this further, we surveyed
our adult CF patients who had undergone CGM as part of the management of their
CFRD.
Method: Thirty patients (20 female) completed a 5-point Likert questionnaire.
Results: Most (83%) found the device easy to use and the instructions clear, and
77% indicated that CGM did not affect their daily routine, but in the remainder it
interfered with sleep (50%), washing activities (42%), and choice of clothing (38%).
Side-effects were reported by only 27%: of these, 57% noted pain and 43% a skin
reaction − 1 patient found these unacceptable. The majority stated they did not
modify their diet (86%) or exercise regimen (90%) during the test. Two thirds also
performed blood glucose monitoring during the duration of CGM as instructed,
with 68% reporting a good correlation with the CGM results. Following this
test, 73% reported a better understanding of blood glucose levels, 47% of insulin
management and 77% of the relationship between dietary intake and blood glucose
levels. Subsequently, 33% have modiﬁed their diet, and 90% would undergo CGM
in future if required.
Conclusions: Although intrusive, CGM is perceived by patients as a useful and
acceptable tool for the monitoring of their CFRD, with a low side-effect proﬁle. We
encourage other CF units to consider its use for the management of this increasingly
common adult CF complication.
237 A retrospective review of the epidemiology of cystic ﬁbrosis
related diabetes (CFRD) in adult cystic ﬁbrosis (CF) patients,
Johannesburg, South Africa
M. Romain1,2, M. Mer1. 1University of Witwatersrand, Pulmonology,
Johannesburg, South Africa; 2Hadassah Hebrew University Hospital, ICU,
Jerusalem, Israel
CF is a common fatal autosomal recessive inherited condition. Survival of patients
with CF has increased due to optimal medical therapy. CFRD is a late complication
of CF. The risk for developing CFRD is increased with increasing age, presence
of exocrine pancreatic insufﬁciency, DF508 homozygous genotype, lower BMI and
female gender.
Aims and Objectives: The aims of the study were to determine the prevalence of
CFRD in the population of CF patients attending the adult CF clinic at Charlotte
Maxeke Johannesburg academic hospital and to determine the characteristics of the
patients with CFRD in terms of age, gender, genotype, lung function, BMI, HBA1c,
use of corticosteroids and pancreatic function. There is currently no data available
in South Africa regarding these statistics.
Methods: A retrospective patient ﬁle review was conducted on all 50 patient ﬁles
in the Adult CF Unit. Patients were classiﬁed as having normal glucose tolerance,
impaired glucose tolerance or CFRD based on the results of oral glucose tolerance
testing (OGTT).
Results: 12 patients (24%) had normal glucose tolerance, 10 (20%) had impaired
glucose tolerance, 23 (46%) had CFRD without fasting hyperglycaemia and 3 pa-
tients (6%) had CFRD with fasting hyperglycaemia. The prevalence of CFRD
was 54%. Statistical analysis failed to demonstrate any signiﬁcant difference in
the characteristics of patients with and without CFRD.
Conclusions: The prevalence of CFRD in this population of CF patients correlates
with the prevalence of CFRD in other CF centers. There were no statistically
signiﬁcant differences in the characteristics of patients with and without CFRD.
238 A study of dietary education for patients with CFRD
R. White1, A.K. Webb1, B. Carter2. 1Manchester Adult Cystic Fibrosis Centre,
Manchester, United Kingdom; 2University of Central Lancashire, School of Health,
Preston, United Kingdom
Background: Structured education programmes for diabetes have been widely
introduced in the UK in recent years, and standards and guidelines advocate their
use. Evidence suggests that CFRD patients may also beneﬁt from such programmes,
in terms of improved glycaemic control and quality of life. However, there is a lack
of studies that have evaluated these programmes for CFRD patients. The aim of
this study was to evaluate a structured dietary education programme for patients
with CFRD using a qualitative approach.
Method: In-depth interviews were conducted with 8 patients (both recently di-
agnosed and long-standing CFRD patients) who had attended a structured CFRD
education programme at Manchester Adult CF Centre. Interview topics included pa-
tients’ perspectives on having CFRD, management of CFRD and their perspectives
on the structured education programme.
Results: The ﬁndings highlighted several areas of living with and managing CFRD
that affect patients. These included the impact of CFRD and accepting the diagnosis,
perspectives on the difﬁculties of managing CFRD and ﬁtting it in with their
lifestyle, and the difference that attending the education programme appeared to
have on these issues.
Conclusion: These ﬁndings suggest the need to support patients with the diagnosis
and ongoing management of CFRD, with the potential for closer working between
psychologists and the CFRD team. There is a need to provide all patients who
have CFRD with ongoing, structured education at the time that is right for them,
separately to their routine clinic visits to allow time to focus on CFRD, and to
provide clear, written information to help improve their understanding of CFRD.
239 Establishment of an F508del pseudoislet model for the study of
CF-related diabetes
N.H. McClenaghan1, P.R. Flatt1, A.G.S. Harper2, C. Kelly2. 1University of Ulster,
SAAD Centre for Diabetes and Pharmacy, Coleraine, United Kingdom; 2Keele
University, Institute for Science and Technology in Medicine, Guy Hilton Research
Centre, Hartshill, Stoke on Trent, United Kingdom
Objectives: CF-related diabetes (CFRD) is poorly understood, but CFTR is ex-
pressed by pancreatic b-cells and is important in insulin secretion [1]. CF animal
models offer new opportunities to study CFTR deﬁcient islets. However, islet
isolation is labour intensive, of low yield and inﬂicts a signiﬁcant animal burden.
Here, we sought to establish an F508del pseudoislet model using the murine MIN6
b-cell line which expresses wild-type CFTR. 3D pseudoislets are preferable to
monolayer cultures because of the enhanced cell–cell contact achieved, which is
needed for normal patterns of insulin secretion.
Methods: MIN6 cells, grown in ultra-low attachment plates (Corning), self-formed
into pseudoislets over one week. Pseudoislets were examined for insulin secretion in
response to stimuli (RIA) and b-cell markers (Western blot). To establish an F508del
pseudoislet model, MIN6 cells were treated with CFTR shRNA (Qiagen), subse-
quently transfected with F508del cDNA (CFTR Expression Core) and pseudoislets
conﬁgured as described [2].
Conclusions: Wild-type MIN6 pseudoislets are similar in size and morphology to
primary mouse islets and release comparable levels of insulin following stimulation
with glucose, nutrients and drugs. Furthermore, they showed enhanced expression
of b-cell markers (GLUT2, glucokinase) when compared with MIN6 monolayers.
These ﬁndings reinforce the utility of this model to study basic mechanisms of
b-cell biology. The established F508del pseudoislet model will be used for future
studies to determine if CFRD results from perturbation of normal b-cell function
because of the basic CFTR defect.
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